The Benefits & Risks of Retatrutide WATCH BEFORE TAKING
Dr. Jones, DC — The Benefits & Risks of Retatrutide WATCH BEFORE TAKING
Channel: Dr. Jones, DC · Our label: Chiropractor / clinician creator · Source: youtube.com/watch?v=8u_dbcbi2po
What this video covers
That’s what came off in the retachai trial at the highest dose and it is the biggest number that anybody has produced in obesity medicine. So let me tell you why I still tell some patients to stay on the drug that they’re already taking. For example, the most common one would be tzepide because we don’t really say that with some glutide as much because that number has a second half that nobody puts in the headline. And there’s a question about coming off this compound that I couldn’t find an answer anywhere in the published data.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- That’s what came off in the retachai trial at the highest dose and it is the biggest number that anybody has produced in obesity medicine.
- Jones DC and I coach thousands of patients through GLP1 and metabolic health strategies.
- This is from the whole class of GLP1s and it’s something that I’ve been watching in our clinic for years.
- Okay, so now the risks and I want to be clear about what I’m doing here because I have a whole separate video on managing side effects.
- At the highest dose in the trials, roughly 11% of people stopped because of the side effects.
- With us, prescribing and dosing is done by licensed prescribers working from real blood work in a detailed history.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.